We’re committed to our mission of finding new treatments that may help improve the lives of people with cancer. Our clinical trials for kidney cancer study investigational medications alone, or in combination with other study medications or standard of care therapy. We perform these trials to see if they can help prevent, find, or treat cancer.
Kidney Cancer is cancer that starts in the kidney. Renal Cell Carcinoma (RCC) is the most common type of kidney cancer and forms in very small tubes of the kidney.
Symptoms usually do not appear until the tumor may already be large and metastatic. Gross or microscopic hematuria is the most common symptom to appear, followed by flank pain, and a large mass.
There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.